WASHINGTON, D.C.: The biotech company Pfizer said Wednesday that a completed study of its experimental Covid-19 vaccine showed it is 95 percent effective.
Pfizer said the vaccine had no serious side effects and that the company will apply for emergency use authorization from US regulators within a matter of days.
“The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic,” said Pfizer CEO Albert Bourla.